<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: RE: Performance enhancement with selegiline</title>
<meta name="Author" content="gts (gts_2000@yahoo.com)">
<meta name="Subject" content="RE: Performance enhancement with selegiline">
<meta name="Date" content="2003-02-17">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>RE: Performance enhancement with selegiline</h1>
<!-- received="Mon Feb 17 14:40:57 2003" -->
<!-- isoreceived="20030217214057" -->
<!-- sent="Mon, 17 Feb 2003 16:42:15 -0500" -->
<!-- isosent="20030217214215" -->
<!-- name="gts" -->
<!-- email="gts_2000@yahoo.com" -->
<!-- subject="RE: Performance enhancement with selegiline" -->
<!-- id="000001c2d6cd$71d09510$7f4a87d8@MyPC" -->
<!-- charset="us-ascii" -->
<!-- inreplyto="001301c2d6c6$b63cc5e0$3e553f94@GaryMiller01" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> gts (<a href="mailto:gts_2000@yahoo.com?Subject=RE:%20Performance%20enhancement%20with%20selegiline"><em>gts_2000@yahoo.com</em></a>)<br>
<strong>Date:</strong> Mon Feb 17 2003 - 14:42:15 MST
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="2899.html">Emlyn O'regan: "RE: Aim or ICQ, other messengers?"</a>
<ul>
<li><strong>Previous message:</strong> <a href="2897.html">Gary Miller: "RE: Performance enhancement with selegiline"</a>
<li><strong>In reply to:</strong> <a href="2897.html">Gary Miller: "RE: Performance enhancement with selegiline"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="3095.html">Rafal Smigrodzki: "RE: Performance enhancement with selegiline"</a>
<li><strong>Reply:</strong> <a href="3095.html">Rafal Smigrodzki: "RE: Performance enhancement with selegiline"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#2898">[ date ]</a>
<a href="index.html#2898">[ thread ]</a>
<a href="subject.html#2898">[ subject ]</a>
<a href="author.html#2898">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
Gary Miller asks:
<br>
<p><em>&gt; Any suggestions as to how to obtain?
</em><br>
<em>&gt; 
</em><br>
<em>&gt; Best Source?
</em><br>
<em>&gt; 
</em><br>
<em>&gt; And what the estimated monthly cost of supplementation would be?
</em><br>
<em>&gt; 
</em><br>
<em>&gt; Did I read earlier it had to be injected?
</em><br>
<p>Normally selegiline (deprenyl) is not injected. It is taken orally, by
<br>
tablet or solution. 
<br>
<p>One reliable source of selegiline (deprenyl) is an overseas company
<br>
called International Antiaging Systems (IAS). You can order online from
<br>
IAS at www.antiaging-systems.com. I can vouch for this firm's integrity;
<br>
I and my friends (&quot;customers&quot;)  have been doing business with IAS for
<br>
many years. 
<br>
<p>Selegiline (deprenyl) can be purchased at IAS in liquid or tablet form.
<br>
There are some theoretical reasons to believe the liquid form is
<br>
superior to the tablet form, but personally I take it in tablet form
<br>
(mainly because I have a huge personal inventory of 5mg tablets).
<br>
<p>Here is pricing information about the two deprenyl products offered by
<br>
IAS:
<br>
<p>Deprenyl Liquid (SeleprylR) 12ml 300mg bottle. 
<br>
Price:  $69.95  
<br>
This is selegiline in a citrate base. 1 drop equals 1mg. There are 300mg
<br>
in one bottle.
<br>
<p>Deprenyl Tablets (JumexR) 50 x 5mg tablets 
<br>
Price: (3 or fewer items) $39.95 
<br>
Price: (4 or more items) $37.50  
<br>
<p>The proper dosage for healthy people is probably a function of age.
<br>
Younger people should take lower doses. A friend of mine (Dr. Ward Dean,
<br>
M.D.) has worked out a suggested dosage schedule by age group. I will
<br>
post it later if anyone is interested. In the meantime I suggest that
<br>
healthy middle-aged people start with just 1 mg per day. This is a very
<br>
small dose: it is only about 1/10 to 1/30 the dose used typically for
<br>
purposes of treating neurodegenerative diseases like Parkinson's and
<br>
Alzheimer's.
<br>
<p>-gts
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="2899.html">Emlyn O'regan: "RE: Aim or ICQ, other messengers?"</a>
<li><strong>Previous message:</strong> <a href="2897.html">Gary Miller: "RE: Performance enhancement with selegiline"</a>
<li><strong>In reply to:</strong> <a href="2897.html">Gary Miller: "RE: Performance enhancement with selegiline"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="3095.html">Rafal Smigrodzki: "RE: Performance enhancement with selegiline"</a>
<li><strong>Reply:</strong> <a href="3095.html">Rafal Smigrodzki: "RE: Performance enhancement with selegiline"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#2898">[ date ]</a>
<a href="index.html#2898">[ thread ]</a>
<a href="subject.html#2898">[ subject ]</a>
<a href="author.html#2898">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Mon Feb 17 2003 - 14:43:31 MST
</em></small></p>
</body>
</html>
